ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,877.44
-0.30%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. AQSE
  6. HUTCHMED China Limited (HCM.GB)

  7. HUTCHMED China Limited (HCM.GB) Noticias

HCM.GB

HUTCHMED China (HCM.GB)

HUTCHMED China Limited
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AQSE:HCM.GB
FechaHoraFuenteTítuloSímboloCompañía
29/12/202302:30UK RegulatoryHutchmed (China) Limited Total Voting RightsAQSE:HCM.GBHUTCHMED China Limited
29/12/202302:30UK RegulatoryHutchmed (China) Limited Blocklisting Six Monthly ReturnAQSE:HCM.GBHUTCHMED China Limited
21/12/202304:00UK RegulatoryHutchmed (China) Limited Overseas Regulatory AnnouncementAQSE:HCM.GBHUTCHMED China Limited
09/11/202301:00UK RegulatoryHutchmed (China) Limited U.S. FDA Approval of FRUZAQLA(TM) (fruquintinib)AQSE:HCM.GBHUTCHMED China Limited
24/10/202303:30UK RegulatoryHutchmed (China) Limited Vesting of awards under the LTIPAQSE:HCM.GBHUTCHMED China Limited
14/09/202303:30UK RegulatoryHutchmed (China) Limited Director's Share DealingAQSE:HCM.GBHUTCHMED China Limited
21/08/202301:00UK RegulatoryHutchmed (China) Limited Sovleplenib Phase 3 Study Meets Primary EndpointAQSE:HCM.GBHUTCHMED China Limited
07/08/202303:30UK RegulatoryHutchmed (China) Limited Exercise of Share Options by a DirectorAQSE:HCM.GBHUTCHMED China Limited
31/07/202306:00UK RegulatoryHutchmed (China) Limited Interim Results and Business UpdatesAQSE:HCM.GBHUTCHMED China Limited
13/07/202303:30UK RegulatoryHutchmed (China) Limited Changes to Board and Technical CommitteeAQSE:HCM.GBHUTCHMED China Limited
26/06/202303:30UK RegulatoryHutchmed (China) Limited HUTCHMED to Announce 2023 Half-Year ResultsAQSE:HCM.GBHUTCHMED China Limited
16/06/202301:00UK RegulatoryHutchmed (China) Limited Phase III FRESCO-2 Results in The LancetAQSE:HCM.GBHUTCHMED China Limited
15/06/202309:39UK RegulatoryHutchmed (China) Limited MAA of Fruquintinib Validated by the EMAAQSE:HCM.GBHUTCHMED China Limited
06/06/202304:00UK RegulatoryHutchmed (China) Limited LTIP and Share Option SchemeAQSE:HCM.GBHUTCHMED China Limited
26/05/202301:00UK RegulatoryHutchmed (China) Limited Fruquintinib NDA Granted Priority Review by FDAAQSE:HCM.GBHUTCHMED China Limited
17/05/202303:30UK RegulatoryHutchmed (China) Limited Standard form for notification of major holdingsAQSE:HCM.GBHUTCHMED China Limited
12/05/202307:15UK RegulatoryHutchmed (China) Limited Annual General Meeting Poll ResultsAQSE:HCM.GBHUTCHMED China Limited
12/05/202303:30UK RegulatoryHutchmed (China) Limited Board of Directors and Board Committee MembershipAQSE:HCM.GBHUTCHMED China Limited
10/05/202303:30UK RegulatoryHutchmed (China) Limited Appointment of Independent NEDAQSE:HCM.GBHUTCHMED China Limited
11/04/202303:30UK RegulatoryHutchmed (China) Limited 2022 Annual Report and Notice of AGMAQSE:HCM.GBHUTCHMED China Limited
11/04/202303:30UK RegulatoryHutchmed (China) Limited Intended Retirement of Independent NEDAQSE:HCM.GBHUTCHMED China Limited
28/02/202302:30UK RegulatoryHutchmed (China) Limited 2022 Full Year Results and Business UpdatesAQSE:HCM.GBHUTCHMED China Limited
31/01/202302:30UK RegulatoryHutchmed (China) Limited Notice of ResultsAQSE:HCM.GBHUTCHMED China Limited
23/01/202302:00UK RegulatoryHutchmed (China) Limited License to Takeda for Fruquintinib outside ChinaAQSE:HCM.GBHUTCHMED China Limited
18/01/202308:30UK RegulatoryHutchmed (China) Limited Inclusion of ORPATHYS in NRDL in ChinaAQSE:HCM.GBHUTCHMED China Limited
15/11/202201:00UK RegulatoryHutchmed (China) Limited HUTCHMED Announces Strategy UpdateAQSE:HCM.GBHUTCHMED China Limited
14/11/202201:00UK RegulatoryHutchmed (China) Limited Positive Topline Phase 3 Result in FruquintinibAQSE:HCM.GBHUTCHMED China Limited
14/09/202205:00UK RegulatoryHutchmed (China) Limited Share Option Scheme and Long Term Incentive PlanAQSE:HCM.GBHUTCHMED China Limited
08/09/202201:00UK RegulatoryHutchmed (China) Limited FRESCO-2 Colorectal Cancer MRCT Data HighlightsAQSE:HCM.GBHUTCHMED China Limited
23/08/202204:00UK RegulatoryHutchmed (China) Limited Holding(s) in CompanyAQSE:HCM.GBHUTCHMED China Limited
 Showing the most relevant articles for your search:AQSE:HCM.GB

Su Consulta Reciente

BFNX
PASETH
EU
G744S
G744S
NASDAQ
FLQNPX
Homebuilders Recovery Se...
COIN
POGGUST
POG Coin [Polygonum]
UNSW
KASHETH
Kids Cash
BIT
I07856
Intesa Sanpaolo
BIBX
RESBTC
Resistance
COIN
XAXUSD
Artax
NASDAQ
APOG
Apogee Enterprises
COIN
DORGBP
NASDAQ
ABADFXX
Hsbc Usa Inc Capped Dual...
BIT
PUIG
Invesco USD Corporate Bo...
COIN
SHOWETH
NASDAQ
ITHX
ITHAX Acquisition
NEO
CESG
CI MSCI World ESG Impact...
NASDAQ
AAXSVXX
Hsbc Usa Inc Autocallabl...
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados